Page 1

TABLE OF CONTENTS ( Mark One ) ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 20 - F REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR ( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ For the transition period from to OR SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission file number : 001-39446 Cure Vac N.V. ( Exact name of Registrant as specified in its charter ) The Netherlands ( Jurisdiction of incorporation or organization ) Friedrich - Miescher - Strasse 15 , 72076 Tübingen , Germany +49 7071 9883 0 ( Address of principal executive offices ) Franz - Werner Haas Chief Executive Officer Friedrich - Miescher - Strasse 15 , 72076 Tübingen , Germany info@curevac.com ( Name , Telephone , E - mail and / or Facsimile number and Address of Company Contact Person ) Securities registered or to be registered pursuant to Section 12 ( b ) of the Act : Title of each class Common shares , par value € 0.12 per share Trading Symbol " CVAC " Securities registered or to be registered pursuant to Section 12 ( g ) of the Act : None Name of each exchange on which registered The NASDAQ Global Market Securities for which there is a reporting obligation pursuant to Section 15 ( d ) of the Act : None Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report .